VOR

Vor Biopharma Inc.

2.13 USD
-0.03 (-1.39%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vor Biopharma Inc. stock is down -12.35% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 February’s closed higher than January.

About Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.